Observational analysis highlights promising outcomes of salvage surgery in non-small cell lung cancer, suggesting potential in select patients post-therapy.
Key Points
Salvage surgery after target therapy or immunotherapy achieved a pathological complete response in 36% of patients.
Among 30 analyzed patients, complications occurred in 20%, and no peri-operative mortality was reported.
Most surgeries involved lobectomy/bilobectomy, with 22 patients initially contraindicated due to N2 involvement.
Median follow-up was 12 months, during which recurrence was observed in 5 patients, with 4 deaths recorded.